The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis
Abstract
BACKGROUND: In this nationwide prospective cohort study, we evaluated the implementation of adjunctive dexamethasone therapy in Dutch adults with pneumococcal meningitis. METHODS: From March 2006 through January 2009, all Dutch patients over 16 years old with community-acquired pneumococcal meningitis were prospectively evaluated. Outcome was classified as unfavorable (defined by a Glasgow Outcome Scale score of 1 to 4 points at discharge) or favorable (a score of 5). Clinical characteristics and outcome were compared with a similar nationwide cohort of 352 patients with pneumococcal meningitis from a previous period before guidelines recommended dexamethasone therapy (1998-2002). A multivariable prognostic model was used to adjust for differences in case mix between the 2 cohorts. RESULTS: We evaluated 357 episodes with pneumococcal meningitis in 2006-2009. Characteristics on admission were comparable with the earlier cohort (1998-2002). Dexamethasone was started with or before the first dose of antibiotics in 84% of episodes in 2006-2009 and 3% in 1998-2002. At discharge, unfavorable outcome was present in 39% in 2006-2009 and 50% in 1998-2002 (odds ratio [OR] 0.63; 95% confidence interval [CI] 0.46-0.86; p = 0.002). Rates of death (20% vs 30%; p = 0.001) and hearing loss (12% vs 22%; p = 0.001) were lower in 2006-2009. Differences in outcome remained after adjusting for differences in case mix between cohorts. CONCLUSIONS: Dexamethasone therapy has been implemented on a large scale as adjunctive treatment of adults with pneumococcal meningitis in the Netherlands. The prognosis of pneumococcal meningitis on a national level has substantially improved after the introduction of adjunctive dexamethasone therapy. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that dexamethasone (10 mg IV, given every 6 hours for 4 days started before or with the first dose of parenteral antibiotics) reduced the proportion of patients with unfavorable outcomes (Glasgow Outcome Scale score of 1 to 4) in the 2006-2009 cohort, as compared to the 1998-2002 cohort (39% vs 50%; OR 0.63; 95% CI 0.46-0.86; p = 0.002). Mortality rate (20% vs 30%; absolute risk difference 10%; 95% CI 4%-17%; p = 0.001) was also lower in 2006-2009.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A comparison of observational studies and randomized, controlled trials.
Benson, K., & Hartz, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422506 · Cited by 2,347
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Self-citationObservational research, randomised trials, and two views of medical science
Vandenbroucke, J. P. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050067 · Cited by 416
MacLehose, Reeves, Harvey, Sheldon, Russell, & Black (2000) · Health Technology Assessment · doi:10.3310/hta4340 · Cited by 311
Research works printed but not linked: 17
- 10.1016/S1474-4422(05)70288-X · DOI · Paper page
- 10.1093/infdis/151.3.528 · DOI · Paper page
- 10.1172/JCI109850 · DOI · Paper page
- 10.1056/NEJMoa021334 · DOI · Paper page
- 10.1056/NEJMoa065711 · DOI · Paper page
- 10.1056/NEJMoa070852 · DOI · Paper page
- 10.1086/522534 · DOI · Paper page
- 10.1016/S0140-6736(02)09458-8 · DOI · Paper page
- 10.1016/S1474-4422(10)70023-5 · DOI · Paper page
- 10.1056/NEJMra052116 · DOI · Paper page
- 10.1111/j.1468-1331.2008.02193.x · DOI · Paper page
- 10.1001/jama.1989.03430190084036 · DOI · Paper page
- 10.1093/jac/49.4.661 · DOI
- 10.1002/sim.4780020222 · DOI · Paper page
- 10.1086/432007 · DOI · Paper page
- 10.1086/527385 · DOI · Paper page
- 10.1056/NEJMp048246 · DOI · Paper page
Cited by
Corticosteroids for acute bacterial meningitis
Brouwer, M. C., McIntyre, P., Prasad, K., & van de Beek, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004405.pub5 · Cited by 809
Self-citationPathogenesis and Pathophysiology of Pneumococcal Meningitis
Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., & van de Beek, D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-11 · Cited by 492
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients
Cook, A. M., Morgan Jones, G., Hawryluk, G. W. J., Mailloux, P., McLaughlin, D., Papangelou, A., Samuel, S., Tokumaru, S., Venkatasubramanian, C., Zacko, C., et al. (2020) · Neurocritical Care · doi:10.1007/s12028-020-00959-7 · Cited by 447
Bijlsma, M. W., Brouwer, M. C., Kasanmoentalib, E. S., Kloek, A. T., Lucas, M. J., Tanck, M. W., van der Ende, A., & van de Beek, D. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00430-2 · Cited by 412
Self-citationAdvances in treatment of bacterial meningitis
van de Beek, D., Brouwer, M. C., Thwaites, G. E., & Tunkel, A. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61186-6 · Cited by 336
Self-citation
Metadata
- Authors
- Brouwer, M. C., Heckenberg, S. G. B., de Gans, J., Spanjaard, L., Reitsma, J. B., & van de Beek, D.
- Venue
- Neurology
- Published
- 2010-10-26
- Volume
- 75
- Issue
- 17
- Pages
- 1533-1539
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2135281873
- Cited by
- 172
- References
- 5
- FWCI
- 14.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. https://app.cochat.ai/papers/10.1212/wnl.0b013e3181f96297
- The paper
- Brouwer, M. C., Heckenberg, S. G. B., de Gans, J., Spanjaard, L., Reitsma, J. B., & van de Beek, D. (2010). Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology. https://doi.org/10.1212/wnl.0b013e3181f96297
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.